Renasant Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,668
Closed -$255K 159
2025
Q1
$255K Sell
3,668
-1,507
-29% -$124K 0.17% 136
2024
Q4
$445K Sell
5,175
-327
-6% -$35.4K 0.29% 97
2024
Q3
$655K Buy
5,502
+919
+20% +$123K 0.43% 79
2024
Q2
$654K Sell
4,583
-141
-3% -$18.7K 0.45% 75
2024
Q1
$607K Sell
4,724
-215
-4% -$25.6K 0.43% 78
2023
Q4
$511K Buy
4,939
+70
+1% +$6.92K 0.41% 80
2023
Q3
$443K Sell
4,869
-311
-6% -$27.4K 0.37% 94
2023
Q2
$419K Sell
5,180
-1,266
-20% -$103K 0.34% 97
2023
Q1
$513K Buy
6,446
+678
+12% +$48.1K 0.4% 84
2022
Q4
$390K Buy
5,768
+150
+3% +$8.79K 0.29% 106
2022
Q3
$280K Buy
5,618
+490
+10% +$26.2K 0.25% 130
2022
Q2
$286K Buy
5,128
+34
+0.7% +$1.89K 0.23% 133
2022
Q1
$283K Hold
5,094
0.19% 157
2021
Q4
$285K Buy
+5,094
New +$276K 0.19% 157
2021
Q3
Sell
-4,894
Closed -$204K 190
2021
Q2
$204K Buy
+4,894
New +$190K 0.15% 183

Other funds holding NVO

Renasant Bank's NVO Position: Q2 2025 in Review

Renasant Bank sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,668 shares — an estimated $255K sold.

Renasant Bank first reported a position in NVO in Q2 2021 and held it in 15 quarters. The position peaked at $655K in Q3 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Renasant Bank reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Renasant Bank sold 3,668 Novo Nordisk shares in Q2 2025, an estimated $255K.
  • Renasant Bank first reported a position in Novo Nordisk in Q2 2021 and held it in 15 quarters.
  • Renasant Bank's Novo Nordisk position peaked at $655K in Q3 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Renasant Bank's 13F filing for Q2 2025, filed 8 Aug 2025.